Cardoso João, Castro Ivo, Gaspar Vasco, Esteves Cristina
Department of Internal Medicine, Hospital de Santarém EPE, Santarém, PRT.
Cureus. 2022 Dec 14;14(12):e32508. doi: 10.7759/cureus.32508. eCollection 2022 Dec.
Coronavirus disease 2019 (COVID-19) is a pandemic that spread rapidly around the world, causing an enormous overload on the health systems of the different affected countries. Among the many different manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, an uncommon complication is the development of pneumomediastinum. In the clinical case presented, the patient was diagnosed with COVID-19 pneumonia and due to severe refractory hypoxemia, she was submitted to therapy with non-invasive ventilation (NIV). After initial stabilization and improvement, there was unexpected clinical deterioration and pneumomediastinum was diagnosed. The purpose of this report is to highlight the importance of considering pneumomediastinum as a complication of COVID-19 pneumonia in cases subjected to non-invasive ventilation.
2019冠状病毒病（COVID-19）是一种在全球迅速传播的大流行病，给不同受影响国家的卫生系统造成了巨大负担。在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的许多不同表现中，纵隔气肿是一种罕见的并发症。在本临床病例中，患者被诊断为COVID-19肺炎，由于严重的难治性低氧血症，接受了无创通气（NIV）治疗。在最初的病情稳定和改善后，出现了意外的临床恶化，诊断为纵隔气肿。本报告的目的是强调在接受无创通气的病例中，将纵隔气肿视为COVID-19肺炎并发症的重要性。
